Else M. Inderberg
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade.
Journal: Frontiers in oncology
Published: February 21, 2026
Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 11, 2025
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.
Journal: Breast cancer research : BCR
Published: March 03, 2025
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity.
Journal: Nature cancer
Published: January 11, 2025
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.
Journal: Cell reports. Medicine
Published: January 03, 2025
Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study.
Journal: Cancer immunology, immunotherapy : CII
Published: November 08, 2024
Protocol for production of tonic CAR T cells with dasatinib.
Journal: STAR protocols
Published: September 27, 2024
LILRB1-directed CAR-T cells for the treatment of hematological malignancies.
Journal: Leukemia
Published: September 06, 2024
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Journal: Oncoimmunology
Published: June 07, 2024
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.
Journal: Journal for immunotherapy of cancer
Published: March 08, 2024
Last Updated: 09/26/2026